Nucks1 synergizes with Trp53 to promote radiation lymphomagenesis in mice

被引:7
|
作者
Yue, Yangbo [1 ,5 ]
Leung, Stanley G. [1 ]
Liu, Yueyong [1 ]
Huang, Yurong [1 ]
Grundt, Kirsten [2 ]
Ostvold, Anne-Carine [2 ]
Jen, Kuang-Yu [3 ]
Schild, David [1 ]
Mao, Jian-Hua [1 ]
Wiese, Claudia [1 ,4 ]
机构
[1] Lawrence Berkeley Natl Lab, Biol Syst & Engn Div, Dept Organismal Syst & Bioresilience, Berkeley, CA 94720 USA
[2] Univ Oslo, Inst Basic Med Sci, Dept Mol Med, N-0317 Oslo, Norway
[3] Univ Calif Davis, Dept Pathol & Lab Med, Sacramento, CA 95817 USA
[4] Colorado State Univ, Dept Environm & Radiol Hlth Sci, Ft Collins, CO 80523 USA
[5] Univ Texas Southwestern Med Ctr Dallas, Dept Dermatol, Dallas, TX 75390 USA
基金
美国国家卫生研究院;
关键词
NUCKS1; double-strand break repair; ionizing radiation; thymic lymphoma; V(D)J recombination; MOUSE THYMIC LYMPHOMAS; DNA-DAMAGE RESPONSE; COMPARATIVE GENOMIC HYBRIDIZATION; HEMATOPOIETIC STEM-CELLS; BREAST-CANCER; HOMOLOGOUS RECOMBINATION; HUMAN-DISEASE; TUMORIGENESIS; EXPRESSION; GENE;
D O I
10.18632/oncotarget.11297
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
NUCKS1 is a 27 kD vertebrate-specific protein, with a role in the DNA damage response. Here, we show that after 4 Gy total-body X-irradiation, Trp53+/Nucks1+/- mice more rapidly developed tumors, particularly thymic lymphoma (TL), than Trp53+/-mice. TLs in both cohorts showed loss of heterozygosity (LOH) of the Trp53+ allele in essentially all cases. In contrast, LOH of the Nucks1+ allele was rare. Nucks1 expression correlated well with Nucks1 gene dosage in normal thymi, but was increased in the majority of TLs from Trp53+/-Nucks1+/-mice, suggesting that elevated Nucks1 message may be associated with progression towards malignancy in vivo. Trp53+/-Nucks1+/-mice frequently succumbed to CD4-CD8-TLs harboring translocations involving Igh but not Tcra/d, indicating TLs in Trp53+/-Nucks1+/mice mostly originated prior to the double positive stage and at earlier lineage than TLs in Trp53+/-mice. Monoclonal rearrangements at Tcrb were more prevalent in TLs from Trp53+/-Nucks1+/-mice, as was infiltration of primary TL cells to distant organs (liver, kidney and spleen). We propose that, in the context of Trp53 deficiency, wild type levels of Nucks1 are required to suppress radiation-induced TL, likely through the role of the NUCKS1 protein in the DNA damage response.
引用
收藏
页码:61874 / 61889
页数:16
相关论文
共 50 条
  • [21] Lysine-specific demethylase 1 accelerates oncogenesis in p53 heterozygous mice via transcriptional repression of the residual Trp53 allele
    Wada, Taeko
    Kikuchi, Jiro
    Koyama, Daisuke
    Honda, Hiroaki
    Furukawa, Yusuke
    LEUKEMIA RESEARCH, 2019, 82 : 29 - 32
  • [22] Cancer and Non-cancer Risks in Normal and Cancer-Prone Trp53 Heterozygous Mice Exposed to High-Dose Radiation
    Carlisle, S. M.
    Burchart, P. A.
    Mitchel, R. E. J.
    RADIATION RESEARCH, 2010, 173 (01) : 40 - 48
  • [23] Rb1 and Trp53 cooperate to suppress prostate cancer lineage plasticity, metastasis, and antiandrogen resistance
    Ku, Sheng Yu
    Rosario, Spencer
    Wang, Yanqing
    Mu, Ping
    Seshadri, Mukund
    Goodrich, Zachary W.
    Goodrich, Maxwell M.
    Labbe, David P.
    Gomez, Eduardo Cortes
    Wang, Jianmin
    Long, Henry W.
    Xu, Bo
    Brown, Myles
    Loda, Massimo
    Sawyers, Charles L.
    Ellis, Leigh
    Goodrich, David W.
    SCIENCE, 2017, 355 (6320) : 78 - 83
  • [24] BRCA1/Trp53 heterozygosity and replication stress drive esophageal cancer development in a mouse model
    He, Ye
    Rivera, Joshua
    Diossy, Miklos
    Duan, Haohui
    Bowman-Colin, Christian
    Reed, Rachel
    Jennings, Rebecca
    Novak, Jesse
    Tran, Stevenson, V
    Cohen, Elizabeth F.
    Szuts, David
    Giobbie-Hurder, Anita
    Bronson, Roderick T.
    Bass, Adam J.
    Signoretti, Sabina
    Szallasi, Zoltan
    Livingston, David M.
    Pathania, Shailja
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2021, 118 (41)
  • [25] Different properties of mammary carcinogenesis induced by two chemical carcinogens, DMBA and PhIP, in heterozygous BALB/c Trp53 knockout mice
    Machida, Yukino
    Imai, Toshio
    ONCOLOGY LETTERS, 2021, 22 (04)
  • [26] Combined Kdm6a and Trp53 Deficiency Drives the Development of Squamous Cell Skin Cancer in Mice
    Shea, Lauren K.
    Akhave, Neal S.
    Sutton, Leslie A.
    Compton, Leigh A.
    York, Conner
    Ramakrishnan, Sai Mukund
    Miller, Christopher A.
    Wartman, Lukas D.
    Chen, David Y.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2023, 143 (02) : 232 - +
  • [27] Impact of a complex nutraceutical supplement on primary tumour formation and metastasis in Trp53/ cancer-prone mice
    Aksenov, Vadim
    Boreham, Douglas
    Rollo, C. David
    MUTAGENESIS, 2014, 29 (03) : 177 - 187
  • [28] Densely Ionizing Radiation Acts via the Microenvironment to Promote Aggressive Trp53-Null Mammary Carcinomas
    Illa-Bochaca, Irineu
    Ouyang, Haoxu
    Tang, Jonathan
    Sebastiano, Christopher
    Mao, Jian-Hua
    Costes, Sylvain V.
    Demaria, Sandra
    Barcellos-Hoff, Mary Helen
    CANCER RESEARCH, 2014, 74 (23) : 7137 - 7148
  • [29] A gain-of-function p53 mutant synergizes with oncogenic NRAS to promote acute myeloid leukemia in mice
    Rajagopalan, Adhithi
    Feng, Yubin
    Gayatri, Meher B.
    Ranheim, Erik A.
    Klungness, Taylor
    Matson, Daniel R.
    Lee, Moon Hee
    Jung, Mabel Minji
    Zhou, Yun
    Gao, Xin
    Nadiminti, Kalyan V. G.
    Yang, David T.
    Tran, Vu L.
    Padron, Eric
    Miyamoto, Shigeki
    Bresnick, Emery H.
    Zhang, Jing
    JOURNAL OF CLINICAL INVESTIGATION, 2023, 133 (24)
  • [30] Synonymous alterations of cancer-associated Trp53 CpG mutational hotspots cause fatal developmental jaw malocclusions but no tumors in knock-in mice
    Epstein, Richard
    Lin, Frank P. Y.
    Brink, Robert
    Blackburn, James
    PLOS ONE, 2023, 18 (04):